What is the difference between AMANTADINE and ROPINIROLE?

AMANTADINE is a Other and ROPINIROLE is a Parkinson's Agent. They reach a similar treatment goal through different pharmacological mechanisms, which is why one may be tolerated by a patient who could not tolerate the other.

Can AMANTADINE and ROPINIROLE be used for the same conditions?

Both medications are prescribed for overlapping indications including Indications and Usage Amantadine Hydrochloride Oral Solution and postencephalitic parkinsonism. Always verify with your prescriber and the current FDA label before switching.

Is Amantadine the same as ropinirole?

No. Amantadine (AMANTADINE) and ropinirole (ROPINIROLE) are distinct medications. They are sometimes confused because of similar branding or because they treat overlapping conditions, but they have different active ingredients and different safety profiles.

Which has fewer side effects, AMANTADINE or ROPINIROLE?

Side-effect frequency varies by individual. The side-effect comparison section on this page shows FAERS-reported events for each drug side by side. FAERS is voluntary reporting, so it reflects what patients and clinicians chose to report, not absolute population risk.

Can I switch from AMANTADINE to ROPINIROLE?

Switching medications should always be done under prescriber supervision. The "patient stories" section on this page includes accounts from people who have made the switch and what their transition felt like, but those are individual experiences, not protocols.

AMANTADINE vs ROPINIROLE

Compare AMANTADINE (Amantadine) and ROPINIROLE (ropinirole) — clinical data, side effects, and patient experiences.

AMANTADINE

Amantadine · Other

How it works

Other agent

Approved for

Indications and Usage Amantadine Hydrochloride Oral Solution

postencephalitic parkinsonism

amantadine hydrochloride is less effective than levodopa

(-)-3-(3

OralTablet

ROPINIROLE

ropinirole, Requip · Parkinson's Agent

How it works

12.1 Mechanism of Action Ropinirole is a non-ergoline dopamine agonist. The precise mechanism of action of ropinirole as a treatment for Parkinson’s disease is unknown, although it...

Approved for

See full prescribing information

OralTablet

Quick Comparison

AMANTADINEROPINIROLE

Drug Class

Other

Parkinson's Agent

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

AMANTADINE

Falls

>10%

Drug Not Working

1-10%

Fatigue

1-10%

Dizziness

1-10%

Tremor

1-10%

Nausea

1-10%

Weakness

1-10%

Condition Worsened

0.1-1%

ROPINIROLE

Drug Not Working

>10%

Falls

1-10%

Fatigue

1-10%

Nausea

1-10%

Dizziness

1-10%

Shortness of Breath

1-10%

Diarrhea

1-10%

Weakness

1-10%

FDA Warnings

AMANTADINE

WARNINGS Deaths : Deaths have been reported from overdose with amantadine hydrochloride
Deaths due to drug accumulation (overdose) have been reported in patients with renal impairment, who were prescribed higher than recommended doses of amantadine hydrochloride for their level of renal function (see DOSAGE AND ADMINISTRATION ; Dosage of Impaired Renal Function and OVERDOSAGE )
Suicide Attempts : Suicide attempts, some of which have been fatal, have been reported in patients treated with amantadine hydrochloride, many of whom received short courses for influenza treatment or prophylaxis
Because of the possibility of serious adverse effects, caution should be observed when prescribing amantadine hydrochloride to patients being treated with drugs having CNS effects, or for whom the potential risks outweigh the benefit of treatment

ROPINIROLE

5 WARNINGS AND PRECAUTIONS Sudden onset of sleep and somnolence may occur ( 5
Although many of these patients reported somnolence while on ropinirole, some perceived that they had no warning signs, such as excessive drowsiness, and believed that they were alert immediately prior to the event
Before initiating treatment with ropinirole, patients should be advised of the potential to develop drowsiness and specifically asked about factors that may increase the risk with ropinirole such as concomitant sedating medications or alcohol, the presence of sleep disorders (other than RLS), and concomitant medications that increase ropinirole plasma levels (e
Patients on ropinirole should be monitored for signs and symptoms of orthostatic hypotension, especially during dose escalation, and should be informed of the risk for syncope and hypotension [ see Patient Counseling Information ( 17 )]

Clinical Trial Data

No head-to-head clinical studies found for AMANTADINE vs ROPINIROLE.

AMANTADINE vs ROPINIROLE: What You Should Know

Key Differences

AMANTADINE is a Other, while ROPINIROLE belongs to the Parkinson's Agent class. This means they work through different pharmacological mechanisms, which may influence both efficacy and side effect profiles.

Safety Considerations

AMANTADINE carries 4 FDA warnings. ROPINIROLE carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

PRAMIPEXOLE DIHYDROCHLORIDE vs ROPINIROLE→ENTACAPONE vs ROPINIROLE→RASAGILINE vs ROPINIROLE→ROPINIROLE vs ROPINIROLE HYDROCHLORIDE→CARBIDOPA AND LEVODOPA vs ROPINIROLE→LEVODOPA vs ROPINIROLE→

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

AMANTADINE: DailyMed label · FAERS adverse events · ClinicalTrials.gov
ROPINIROLE: DailyMed label · FAERS adverse events · ClinicalTrials.gov

Loading comparison data...

AMANTADINE vs ROPINIROLE

Compare AMANTADINE (Amantadine) and ROPINIROLE (ropinirole) — clinical data, side effects, and patient experiences.

AMANTADINE

Amantadine · Other

How it works

Other agent

Approved for

Indications and Usage Amantadine Hydrochloride Oral Solution

postencephalitic parkinsonism

amantadine hydrochloride is less effective than levodopa

(-)-3-(3

OralTablet

ROPINIROLE

ropinirole, Requip · Parkinson's Agent

How it works

12.1 Mechanism of Action Ropinirole is a non-ergoline dopamine agonist. The precise mechanism of action of ropinirole as a treatment for Parkinson’s disease is unknown, although it...

Approved for

See full prescribing information

OralTablet

Quick Comparison

AMANTADINEROPINIROLE

Drug Class

Other

Parkinson's Agent

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

AMANTADINE

Falls

>10%

Drug Not Working

1-10%

Fatigue

1-10%

Dizziness

1-10%

Tremor

1-10%

Nausea

1-10%

Weakness

1-10%

Condition Worsened

0.1-1%

ROPINIROLE

Drug Not Working

>10%

Falls

1-10%

Fatigue

1-10%

Nausea

1-10%

Dizziness

1-10%

Shortness of Breath

1-10%

Diarrhea

1-10%

Weakness

1-10%

FDA Warnings

AMANTADINE

WARNINGS Deaths : Deaths have been reported from overdose with amantadine hydrochloride
Deaths due to drug accumulation (overdose) have been reported in patients with renal impairment, who were prescribed higher than recommended doses of amantadine hydrochloride for their level of renal function (see DOSAGE AND ADMINISTRATION ; Dosage of Impaired Renal Function and OVERDOSAGE )
Suicide Attempts : Suicide attempts, some of which have been fatal, have been reported in patients treated with amantadine hydrochloride, many of whom received short courses for influenza treatment or prophylaxis
Because of the possibility of serious adverse effects, caution should be observed when prescribing amantadine hydrochloride to patients being treated with drugs having CNS effects, or for whom the potential risks outweigh the benefit of treatment

ROPINIROLE

5 WARNINGS AND PRECAUTIONS Sudden onset of sleep and somnolence may occur ( 5
Although many of these patients reported somnolence while on ropinirole, some perceived that they had no warning signs, such as excessive drowsiness, and believed that they were alert immediately prior to the event
Before initiating treatment with ropinirole, patients should be advised of the potential to develop drowsiness and specifically asked about factors that may increase the risk with ropinirole such as concomitant sedating medications or alcohol, the presence of sleep disorders (other than RLS), and concomitant medications that increase ropinirole plasma levels (e
Patients on ropinirole should be monitored for signs and symptoms of orthostatic hypotension, especially during dose escalation, and should be informed of the risk for syncope and hypotension [ see Patient Counseling Information ( 17 )]

Clinical Trial Data

No head-to-head clinical studies found for AMANTADINE vs ROPINIROLE.

AMANTADINE vs ROPINIROLE: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.